• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

含有5'-硫代核苷的寡核苷酸的体外和体内生物物理性质

In vitro and in vivo biophysical properties of oligonucleotides containing 5'-thio nucleosides.

作者信息

Islam Md Ariful, Waki Reiko, Fujisaka Aki, Ito Kosuke Ramon, Obika Satoshi

机构信息

Graduate School of Pharmaceutical Sciences, Osaka University.

出版信息

Drug Discov Ther. 2016;10(5):263-270. doi: 10.5582/ddt.2016.01055.

DOI:10.5582/ddt.2016.01055
PMID:27890900
Abstract

Phosphorothioate modification is one of the most widely investigated and promising chemical modifications in oligonucleotide (ON) based therapeutics. Structurally similar 5'-thio or phosphorothiolate-modified nucleotides, in which a 5'-bridging oxygen is replaced with a sulfur atom, are gaining importance for ON-based research. Several reports have been published describing the synthesis of 5'-thio-modified ONs but no detailed in vitro and in vivo data are available. Here, we report the synthesis of 5'-thio-modified 2'-deoxy-5-methylcytidine. 5'-Thio-modified thymidine and 2'-deoxy-5-methylcytidine were incorporated into target ONs, then we evaluated their binding affinity, nuclease stability, RNase H mediated scission, stability in blood serum, and in vitro and in vivo activity. This is the first report showing the influence of 5'-thio-modified antisense ONs in in vitro and in vivo experiments.

摘要

硫代磷酸酯修饰是基于寡核苷酸(ON)的治疗中研究最广泛且最具前景的化学修饰之一。结构相似的5'-硫代或硫代磷酸酯修饰的核苷酸,其中一个5'-桥连氧被硫原子取代,在基于ONs的研究中变得越来越重要。已经发表了几篇描述5'-硫代修饰的ONs合成的报告,但尚无详细的体外和体内数据。在此,我们报告了5'-硫代修饰的2'-脱氧-5-甲基胞苷的合成。将5'-硫代修饰的胸苷和2'-脱氧-5-甲基胞苷掺入目标ONs中,然后我们评估了它们的结合亲和力、核酸酶稳定性、RNase H介导的切割、血清稳定性以及体外和体内活性。这是第一份显示5'-硫代修饰的反义ONs在体外和体内实验中影响的报告。

相似文献

1
In vitro and in vivo biophysical properties of oligonucleotides containing 5'-thio nucleosides.含有5'-硫代核苷的寡核苷酸的体外和体内生物物理性质
Drug Discov Ther. 2016;10(5):263-270. doi: 10.5582/ddt.2016.01055.
2
Synthesis and biophysical properties of 5'-thio-2',4'-BNA/LNA oligonucleotide.5'-硫代-2',4'-BNA/LNA 寡核苷酸的合成及生物物理性质。
Bioorg Med Chem. 2018 Jul 23;26(12):3634-3638. doi: 10.1016/j.bmc.2018.05.040. Epub 2018 May 23.
3
Reverse-direction (5'-->3') synthesis of oligonucleotides containing a 3'-S-phosphorothiolate linkage and 3'-terminal 3'-thionucleosides.含有 3′-硫代磷酸酯键和 3′-末端 3′-硫代核苷的寡核苷酸的反向(5′→3′)合成。
Org Biomol Chem. 2010 Mar 21;8(6):1463-70. doi: 10.1039/b923545k. Epub 2010 Jan 28.
4
An overview of sugar-modified oligonucleotides for antisense therapeutics.用于反义治疗的糖修饰寡核苷酸概述。
Chem Biodivers. 2011 Sep;8(9):1616-41. doi: 10.1002/cbdv.201100081.
5
Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.Carba-LNA-5MeC/A/G/T 修饰的寡核苷酸表现出碱基特异性的 3'-外切酶活性、热力学稳定性、RNA 选择性和 RNase H 诱导的调节:合成与生物化学。
J Org Chem. 2011 Jun 3;76(11):4408-31. doi: 10.1021/jo200073q. Epub 2011 May 4.
6
Comparison of the RNase H cleavage kinetics and blood serum stability of the north-conformationally constrained and 2'-alkoxy modified oligonucleotides.北构象受限和2'-烷氧基修饰寡核苷酸的核糖核酸酶H切割动力学及血清稳定性比较
Biochemistry. 2007 May 15;46(19):5635-46. doi: 10.1021/bi0620205. Epub 2007 Apr 6.
7
4-Thiofuranoid Glycal: Versatile Glycosyl Donor for the Selective Synthesis of β-anomer of 4'-thionucleoside and its Biological Activities.4-噻吩糖醛苷:用于选择性合成 4'-硫代核苷β-异构体的多功能糖基供体及其生物活性。
Curr Med Chem. 2022;29(21):3684-3731. doi: 10.2174/0929867328666211115121434.
8
In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3' and 5' thiophosphate linkages.含有非手性 3'和 5'硫代磷酸酯键的治疗性寡核苷酸的体外和体内性质。
Nucleic Acids Res. 2020 Jan 10;48(1):63-74. doi: 10.1093/nar/gkz1099.
9
2'-Modified oligonucleotides for antisense therapeutics.用于反义治疗的2'-修饰寡核苷酸。
Curr Top Med Chem. 2007;7(7):641-9. doi: 10.2174/156802607780487713.
10
2'-O-[2-[(N,N-dimethylamino)oxy]ethyl]-modified oligonucleotides inhibit expression of mRNA in vitro and in vivo.2'-O-[2-[(N,N-二甲基氨基)氧基]乙基]修饰的寡核苷酸在体外和体内均可抑制mRNA的表达。
Nucleic Acids Res. 2004 Feb 3;32(2):828-33. doi: 10.1093/nar/gkh220. Print 2004.

引用本文的文献

1
Modified internucleoside linkages for nuclease-resistant oligonucleotides.用于抗核酸酶寡核苷酸的修饰核苷间连接。
RSC Chem Biol. 2020 Dec 8;2(1):94-150. doi: 10.1039/d0cb00136h. eCollection 2021 Feb 1.
2
In vitro and in vivo properties of therapeutic oligonucleotides containing non-chiral 3' and 5' thiophosphate linkages.含有非手性 3'和 5'硫代磷酸酯键的治疗性寡核苷酸的体外和体内性质。
Nucleic Acids Res. 2020 Jan 10;48(1):63-74. doi: 10.1093/nar/gkz1099.